Sphenopalatine Ganglion Block to Prevent Shoulder Pain After Laparoscopic Bariatric Surgery

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02809755

Enrollment

Registered

2016-06-22

Start date

2016-08-08

Completion date

2017-04-03

Last updated

2019-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, laparoscopic gastric banding, band revision, laparoscopic gastric banding sleeve gastrectomy

Brief summary

The purpose of this study is to determine the efficacy of sphenopalatine ganglion (SPG) block to prevent shoulder tip pain following primary laparoscopic gastric banding, band revision, band replacement, primary sleeve gastrectomy or revision of sleeve gastrectomy. Shoulder tip pain (STP) is a common problem after laparoscopic surgery, manifesting in the post-anesthesia care unit and for days or possibly weeks thereafter (Dixon 2005). Systemic analgesics including opioids and non-steroidal anti-inflammatory drugs (NSAIDs) do not reliably relieve STP. This study is designed to determine if the SPG block, a simple and low-risk procedure, effectively treats STP after laparoscopic bariatric surgery.

Detailed description

This is a randomized, placebo-controlled, parallel group prospective, double-blind study. The primary outcome variable will be change in STP from \> 4 before to after treatment in the PACU after primary laparoscopic gastric banding, band revision, band replacement, sleeve gastrectomy, or revision of sleeve gastrectomy. Investigators hope to achieve a decline in STP in 2 units after treatment.

Interventions

DRUG4% Lidocaine

OTHERSaline

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Elective primary laparoscopic gastric banding surgery. * Laparoscopic band revision surgery * Laparoscopic band replacement surgery. * Sleeve gastrectomy. * Revision of sleeve gastrectomy. * American Society of Anesthesiologists Class 2 or 3. * No allergy to study drugs. * Facility with English language to allow compliance with study protocol.

Exclusion criteria

* American Society of Anesthesiologists Class 4 or 5. * Allergy to lidocaine or to any local anesthetic * Allergy to oxymetazoline (Afrin) * Pregnancy * Bleeding diathesis * Known nasal pathology including active sinusitis * Previous nasal surgery * Preoperative anticoagulant use OTHER THAN aspirin 81 mg and/or heparin 5000 U SQ bid administered for DVT prophylaxis. * Acute psychiatric disease * History of chronic right or left shoulder pain * Current opioid use * Any patient that the study team feels will be unable to comply with all protocol related procedures * Concurrent participation in another clinical trial

Design outcomes

Primary

Measure	Time frame	Description
Change in STP as assessed by Numeric Rating Scale (NRS-11), from before to after the treatment in the PACU after receiving a 30-minute unilateral SPG block or bilateral SPG block	Baseline, 30 Minutes	subject will be asked to rate her/his pain from zero to ten with zero being no pain to ten being the worst pain imaginable.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026